18 results
10-Q
2021 Q1
KNTE
Kinnate Biopharma Inc
17 May 21
Quarterly report
4:26pm
and to recoup the costs of our research and development. For further discussion, see “-We may face difficulties from changes to current regulations
10-K
qfksae9 xrj
29 Mar 21
Annual report
4:26pm
DRS
th23v
4 Sep 20
Draft registration statement
12:00am
424B4
q0gvi6c8 mk
3 Dec 20
Prospectus supplement with pricing info
4:48pm
S-1/A
qb827b5nu o9n
30 Nov 20
IPO registration (amended)
6:05am
DRS/A
04f6f
16 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
tih8sx6dxg lss
3 Nov 20
Draft registration statement (amended)
12:00am
S-1
p96w83g34sh8goa
13 Nov 20
IPO registration
5:03pm
- Prev
- 1
- Next